Prostate Health Market: Trends, Opportunities and Competitive Analysis [2023-2028]
Get it in 2-3 working days by ordering today
Prostate Health Market Trends and Forecast
The future of the global prostate health market looks promising with opportunities in pharmacies and e-commerce stores. The global prostate health market is expected to reach an estimated $58.9 billion by 2028 with a CAGR of 9.1% from 2023 to 2028. The major drivers for this market are growing prevalence of benign prostatic hyperplasia and cancer, rising number of prostatitis, and increasing fund for research in BPH treatment.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Prostate Health Market by Segment
The study includes trends and forecast for the global prostate health market by disease indication, treatment outlook, distribution channel, and region, as follows:
Prostate Health Market by Disease Indication [Value ($B) Shipment Analysis from 2017 to 2028]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, prostate health companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the prostate health companies profiled in this report include-
Q1. What is the prostate health market size?
Answer: The global prostate health market is expected to reach an estimated $58.9 billion by 2028.
Q2. What is the growth forecast for prostate health market?
Answer: The global prostate health market is expected to grow with a CAGR of 9.1% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the prostate health market?
Answer: The major drivers for this market are growing prevalence of benign prostatic hyperplasia and cancer, rising number of prostatitis, and increasing fund for research in BPH treatment.
Q4. What are the major segments for prostate health market?
Answer: The future of the prostate health market looks promising with opportunities in pharmacies and e-commerce stores.
Q5. Who are the key prostate health companies?
Answer: Some of the key prostate health companies are as follows:
Answer:Lucintel forecasts that prostate cancer will remain the largest disease indication segment over the forecast period because augmenting cancer cases has influenced the usage of immunotherapies to inhibit prostate cancer cells from spreading. Also, hormone therapy is generally used to effectively treat cancer at the initial stage.
Q7. In prostate health market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest region due to presence of advanced prostate treatment facilities, rising awareness towards prostate health, and growing cases of BPH and prostate cancer in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the global prostate health market by disease indication (prostate cancer, prostatitis, alpha blockers, benign prostate hyperplasia, and others), treatment outlook (cytotoxic agents, hormone ADT, AR directed therapies, PARP inhibitors, and others), and distribution channel (pharmacy, e-commerce stores, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity did occur in the last five years and how did they impact the industry?
For any questions related to prostate health or related to prostate health companies, prostate health market size, prostate health market share, prostate health analysis, prostate health market growth, prostate health market research, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
Prostate Health Market Trends and Forecast
The future of the global prostate health market looks promising with opportunities in pharmacies and e-commerce stores. The global prostate health market is expected to reach an estimated $58.9 billion by 2028 with a CAGR of 9.1% from 2023 to 2028. The major drivers for this market are growing prevalence of benign prostatic hyperplasia and cancer, rising number of prostatitis, and increasing fund for research in BPH treatment.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Prostate Health Market by Segment
The study includes trends and forecast for the global prostate health market by disease indication, treatment outlook, distribution channel, and region, as follows:
Prostate Health Market by Disease Indication [Value ($B) Shipment Analysis from 2017 to 2028]:
- Prostate Cancer
- Prostatitis
- Alpha Blockers
- Benign Prostate Hyperplasia
- Others
- Cytotoxic Agents
- Hormone ADT
- AR Directed Therapies
- PARP Inhibitors
- Others
- Pharmacy
- E-Commerce Stores
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, prostate health companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the prostate health companies profiled in this report include-
- Eli Lilly and Company
- Pfizer
- Merck & Co.
- Abbott
- Endo Pharmaceuticals
- GlaxoSmithKline PLC
- Siemens Healthcare
- Amgen
- AstraZeneca
- Lucintel forecasts that prostate cancer will remain the largest disease indication segment over the forecast period because augmenting cancer cases has influenced the usage of immunotherapies to inhibit prostate cancer cells from spreading. Also, hormone therapy is generally used to effectively treat cancer at the initial stage.
- E-commerce store segment is expected to record the highest growth because they are user-friendly. Moreover, they expand quickly and have begun to replace conventional medical stores. Using e-pharmacy to purchase medicines is simple and useful for persons who live far away and also helps to save time and money.
- North America is expected to remain the largest region due to presence of advanced prostate treatment facilities, rising awareness towards prostate health, and growing cases of BPH and prostate cancer in the region.
- Market Size Estimates: Prostate health market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Prostate health market size by various segments, such as by disease indication, treatment outlook, distribution channel, and region
- Regional Analysis: Prostate health market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different disease indications, treatment outlooks, distribution channels, and regions for the prostate health market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape for the prostate health market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q1. What is the prostate health market size?
Answer: The global prostate health market is expected to reach an estimated $58.9 billion by 2028.
Q2. What is the growth forecast for prostate health market?
Answer: The global prostate health market is expected to grow with a CAGR of 9.1% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the prostate health market?
Answer: The major drivers for this market are growing prevalence of benign prostatic hyperplasia and cancer, rising number of prostatitis, and increasing fund for research in BPH treatment.
Q4. What are the major segments for prostate health market?
Answer: The future of the prostate health market looks promising with opportunities in pharmacies and e-commerce stores.
Q5. Who are the key prostate health companies?
Answer: Some of the key prostate health companies are as follows:
- Eli Lilly and Company
- Pfizer
- Merck & Co.
- Abbott
- Endo Pharmaceuticals
- GlaxoSmithKline PLC
- Siemens Healthcare
- Amgen
- AstraZeneca
Answer:Lucintel forecasts that prostate cancer will remain the largest disease indication segment over the forecast period because augmenting cancer cases has influenced the usage of immunotherapies to inhibit prostate cancer cells from spreading. Also, hormone therapy is generally used to effectively treat cancer at the initial stage.
Q7. In prostate health market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest region due to presence of advanced prostate treatment facilities, rising awareness towards prostate health, and growing cases of BPH and prostate cancer in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the global prostate health market by disease indication (prostate cancer, prostatitis, alpha blockers, benign prostate hyperplasia, and others), treatment outlook (cytotoxic agents, hormone ADT, AR directed therapies, PARP inhibitors, and others), and distribution channel (pharmacy, e-commerce stores, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity did occur in the last five years and how did they impact the industry?
For any questions related to prostate health or related to prostate health companies, prostate health market size, prostate health market share, prostate health analysis, prostate health market growth, prostate health market research, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL PROSTATE HEALTH MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1. Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2. Global Prostate Health Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Prostate Health Market by Disease Indication
3.3.1 Prostate Cancer
3.3.2 Prostatitis
3.3.3 Alpha Blockers
3.3.4 Benign Prostate Hyperplasia
3.3.5 Others
3.4: Global Prostate Health Market by Treatment Outlook
3.4.1 Cytotoxic Agents
3.4.2 Hormone ADT
3.4.3 AR Directed Therapies
3.4.4 PARP Inhibitors
3.4.5 Others
3.5: Global Prostate Health Market by Distribution Channel
3.5.1 Pharmacy
3.5.2 E-Commerce Stores
3.5.3 Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Prostate Health Market by Region
4.2: North American Prostate Health Market
4.2.1: North American Prostate Health Market by Disease Indication: Prostate Cancer, Prostatitis, Alpha Blockers, Benign Prostate Hyperplasia, and Others
4.2.2: North American Prostate Health Market by Distribution Channel: Pharmacy, E-Commerce Stores, and Others
4.3: European Prostate Health Market
4.3.1: European Prostate Health Market by Disease Indication: Prostate Cancer, Prostatitis, Alpha Blockers, Benign Prostate Hyperplasia, and Others
4.3.2: European Prostate Health Market by Distribution Channel: Pharmacy, E-Commerce Stores, and Others
4.4: APAC Prostate Health Market
4.4.1: APAC Prostate Health Market by Disease Indication: Prostate Cancer, Prostatitis, Alpha Blockers, Benign Prostate Hyperplasia, and Others
4.4.2: APAC Prostate Health Market by Distribution Channel: Pharmacy, E-Commerce Stores, and Others
4.5: ROW Prostate Health Market
4.5.1: ROW Prostate Health Market by Disease Indication: Prostate Cancer, Prostatitis, Alpha Blockers, Benign Prostate Hyperplasia, and Others
4.5.2: ROW Prostate Health Market by Distribution Channel: Pharmacy, E-Commerce Stores, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Prostate Health Market by Disease Indication
6.1.2: Growth Opportunities for the Global Prostate Health Market by Treatment Outlook
6.1.3: Growth Opportunities for the Global Prostate Health Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Prostate Health Market by Region
6.2: Emerging Trends in the Global Prostate Health Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Prostate Health Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Prostate Health Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Eli Lilly and Company
7.2: Pfizer
7.3: Merck & Co.
7.4: Abbott
7.5: Endo Pharmaceuticals
7.6: GlaxoSmithKline PLC
7.7: Siemens Healthcare
7.8: Amgen
7.9: AstraZeneca
2. GLOBAL PROSTATE HEALTH MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1. Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2. Global Prostate Health Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Prostate Health Market by Disease Indication
3.3.1 Prostate Cancer
3.3.2 Prostatitis
3.3.3 Alpha Blockers
3.3.4 Benign Prostate Hyperplasia
3.3.5 Others
3.4: Global Prostate Health Market by Treatment Outlook
3.4.1 Cytotoxic Agents
3.4.2 Hormone ADT
3.4.3 AR Directed Therapies
3.4.4 PARP Inhibitors
3.4.5 Others
3.5: Global Prostate Health Market by Distribution Channel
3.5.1 Pharmacy
3.5.2 E-Commerce Stores
3.5.3 Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Prostate Health Market by Region
4.2: North American Prostate Health Market
4.2.1: North American Prostate Health Market by Disease Indication: Prostate Cancer, Prostatitis, Alpha Blockers, Benign Prostate Hyperplasia, and Others
4.2.2: North American Prostate Health Market by Distribution Channel: Pharmacy, E-Commerce Stores, and Others
4.3: European Prostate Health Market
4.3.1: European Prostate Health Market by Disease Indication: Prostate Cancer, Prostatitis, Alpha Blockers, Benign Prostate Hyperplasia, and Others
4.3.2: European Prostate Health Market by Distribution Channel: Pharmacy, E-Commerce Stores, and Others
4.4: APAC Prostate Health Market
4.4.1: APAC Prostate Health Market by Disease Indication: Prostate Cancer, Prostatitis, Alpha Blockers, Benign Prostate Hyperplasia, and Others
4.4.2: APAC Prostate Health Market by Distribution Channel: Pharmacy, E-Commerce Stores, and Others
4.5: ROW Prostate Health Market
4.5.1: ROW Prostate Health Market by Disease Indication: Prostate Cancer, Prostatitis, Alpha Blockers, Benign Prostate Hyperplasia, and Others
4.5.2: ROW Prostate Health Market by Distribution Channel: Pharmacy, E-Commerce Stores, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Prostate Health Market by Disease Indication
6.1.2: Growth Opportunities for the Global Prostate Health Market by Treatment Outlook
6.1.3: Growth Opportunities for the Global Prostate Health Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Prostate Health Market by Region
6.2: Emerging Trends in the Global Prostate Health Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Prostate Health Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Prostate Health Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Eli Lilly and Company
7.2: Pfizer
7.3: Merck & Co.
7.4: Abbott
7.5: Endo Pharmaceuticals
7.6: GlaxoSmithKline PLC
7.7: Siemens Healthcare
7.8: Amgen
7.9: AstraZeneca
